Standout Papers
Citation Impact
Citing Papers
Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long-term outcome
2002
Mutagenicity of chemical carcinogens
1976
Mutagenicities of N-nitrosamines on salmonella
1977
Analysis of the storage effect of diepoxybutane (DEB) in Neurospora crassa
1973
The effects of six years of mutagen testing on our attitude to the problems posed by it
1975
Monophosphoryl lipid A (MPL®)* promotes allergen‐induced immune deviation in favour of Th1 responses
2005
Igg subclass-restricted immune responses to allergens
1990
Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours
2002
Atopic Dermatitis
2008 Standout
Polycystic echinococcosis in tropical America: Echinococcus vogeli and E. oligarthrus
1997
New Applications of Bacterial Systems to Problems in Toxicology
1996
Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
1993
Safety of Various Dosage Regimens during Induction of Sublingual Immunotherapy
2002
Bacterial vaccines: anything but placebo
2000
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The Potential Role of Allergen-Specific Sublingual Immunotherapy in Atopic Dermatitis
2004
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Preparation of human metabolites of propranolol using laboratory‐evolved bacterial cytochromes P450
2005 StandoutNobel
Echinococcosis
2003 Standout
Use of A‐type CpG oligodeoxynucleotides as an adjuvant in allergen‐specific immunotherapy in humans: a phase I/IIa clinical trial
2009
Sublingual immunotherapy induces IL-10–producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation
2007
Safety Considerations in Assessing the Role of Immunotherapy in Allergic Disorders
1994
Clinical and immunologic effects of long‐term sublingual immunotherapy in asthmatic children sensitized to mites:a double‐blind, placebo‐controlled study
2000
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Superiority of an Intranasal Corticosteroid Compared With an Oral Antihistamine in the As-Needed Treatment of Seasonal Allergic Rhinitis
2001
Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial☆☆☆★
1999
Precision of skin prick and puncture tests with nine methods
1991
IgE and mast cells in allergic disease
2012 Standout
Survey of fatalities from skin testing and immunotherapy 1985–1989
1993
Double-blind placebo-controlled immunotherapy with mixed grass-pollen allergoids
1988
Mucosal immunity and vaccines
2005 Standout
Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis
2002
Does Allergen Immunotherapy Alter the Natural Course of Allergic Disorders?
2001
Long‐term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial
1999
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
2004 Standout
Mechanisms of allergen-specific immunotherapy
2011
The link between fungi and severe asthma: a summary of the evidence
2006
Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trial
2001
Fexofenadine reduces nasal congestion in perennial allergic rhinitis
2001
Asthma
2017 Standout
The role of patient training in the management of seasonal rhinitis and asthma: clinical implications
2001
A Multicenter Trial of Specific Local Nasal Immunotherapy
2000
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The biochemistry and medical significance of the flavonoids
2002 Standout
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
2001 Standout
The development of allergic inflammation
2008 StandoutNature
Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys
2006 Standout
Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis☆☆☆★
1999
Asthma
2001 Standout
Effects of immunotherapy with a purified standardized allergen preparation of Dermatophagoides farinae in adults with perennial allergic rhinoconjunctivitis
1994
Anti-IgE as a mast cell–stabilizing therapeutic agent
2006
Basidiomycete allergens
1998
The Role of Cockroach Allergy and Exposure to Cockroach Allergen in Causing Morbidity among Inner-City Children with Asthma
1997 Standout
Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis*
2004
Preseasonal local allergoid immunotherapy to grass pollen in children: a double‐blind, placebo‐controlled, randomized trial
2000
Molecular themes in oncogenesis
1991 StandoutNobel
Evaluation of Impermeable Covers for Bedding in Patients with Allergic Rhinitis
2003
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years
1993
Efficacy of sublingual immunotherapy in asthma: systematic review of randomized‐clinical trials using the Cochrane Collaboration method
2006
Relationships between rhinitis and asthma
1998
IgG4-related disease
2014 Standout
Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis
2007 Standout
Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
2015 Standout
Role of interleukin 10 in specific immunotherapy.
1998 Standout
Outdoor air pollution and asthma
2014 Standout
Effects of budesonide and fluticasone propionate in a placebo‐controlled study on symptoms and quality of life in seasonal allergic rhinitis
2002
Strategies for converting allergens into hypoallergenic vaccine candidates
2004
Functionalized gold nanoclusters as fluorescent labels for immunoassays: Application to human serum immunoglobulin E determination
2015
Oligonucleotide therapy of allergic asthma☆☆☆
1999
House‐dust‐mite sublingual‐swallow immunotherapy (SLIT) in perennial rhinitis: a double‐blind, placebo‐controlled study
2000
Immunotherapy in Allergic Rhinitis: A Prevention for Asthma?
1999
Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion
2009 StandoutNobel
Percutaneous treatment of hydatid cysts (Echinococcus Granulosus)
1990
Immunotherapy with Alpare® in patients with respiratory allergy to Parietaria pollen: a two year double‐blind placebo‐controlled study
1995
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis
2001
Immunotherapy with a standardized Dermatophagoides pteronyssinus extract
1990
Sublingual immunotherapy: a double‐blind, placebo‐controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both
1999
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Systemic Immunological Changes Induced by Administration of Grass Pollen Allergens via the Oral Mucosa during Sublingual Immunotherapy
1999
BIOLOGICAL ACTIVITIES OF SOME PURINE ARABINOSIDES
1975 StandoutNobel
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Analysis of a case of mutagen specificity inNeurospora crassa
1970
In vitro metabolism and microsome-mediated mutagenicity of dialkylnitrosamines in rat, hamster, and mouse tissues.
1975
DNA Damage in Mammalian Cells
1981 StandoutNobel
Atomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
2016 Standout
Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids.
1975 Standout
Position Paper: Immunotherapy with Hymenoptera venoms
1993
Biological, Epidemiological, and Clinical Aspects of Echinococcosis, a Zoonosis of Increasing Concern
2004 Standout
The effect of outdoor fungal spore concentrations on daily asthma severity.
1997
Recombinant allergens for specific immunotherapy
1999
Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems
1980
Low‐dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides
2002
Interventions for enhancing medication adherence
2008 Standout
Post‐marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients
1999
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy
2009
ProTox-II: a webserver for the prediction of toxicity of chemicals
2018 Standout
Revised methods for the Salmonella mutagenicity test
1983 Standout
Genetic toxicity of some important epoxides
1981 Standout
Position Paper: Immunotherapy
1993
Effect of Acupuncture in the Treatment of Seasonal Allergic Rhinitis: A Randomized Controlled Clinical Trial
2002
Sublingual immunotherapy for asthma
2015
Short term screening tests for carcinogens
1976 Nature
Interventions for enhancing medication adherence
2014 Standout
Sensitization to Alternaria and Cladosporium by the age of 4 years
1996
Dietary Carcinogens and Anticarcinogens
1983 StandoutScience
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Recombinant Carp Parvalbumin, the Major Cross-Reactive Fish Allergen: A Tool for Diagnosis and Therapy of Fish Allergy
2002
Analysis of a case of mutagen specificity in Neurospora crassa
1968
Evaluation of six short term tests for detecting organic chemical carcinogens and recommendations for their use
1976 StandoutNature
Carcinogens are Mutagens: A Simple Test System Combining Liver Homogenates for Activation and Bacteria for Detection
1973 Standout
Grass Pollen Immunotherapy Induces Mucosal and Peripheral IL-10 Responses and Blocking IgG Activity
2004
Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.
1975 Standout
System for the evaluation of the risk from chemical mutagens for man: Basic principles and practical recommendations
1976
Reproducibility of Skin Sensitivity Using a Quantitative Skin Prick Test
1985
Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test
1975 Standout
3-Nitrobenzanthrone, a Powerful Bacterial Mutagen and Suspected Human Carcinogen Found in Diesel Exhaust and Airborne Particulates
1997 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Evaluation of the multi-test device for immediate hypersensitivity skin testing
1992
Hidden Killers: Human Fungal Infections
2012 Standout
Some Properties of Partially Purified Mammalian Adenosine Kinase
1967
From Allergen Genes to Allergy Vaccines
2010
Oral immunotherapy in birch pollen hay fever
1987
Allergen injection immunotherapy for seasonal allergic rhinitis
2007
Analysis of a case of mutagen specificity in Neurospora crassa
1972
Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity
1979 StandoutNobel
Identifying Environmental Chemicals Causing Mutations and Cancer
1979 Science
Antioxidant and Antiproliferative Activities of Common Fruits
2002 Standout
Works of H.‐J. Malling being referenced
Current status of allergen immunotherapy
1989
Dimethylnitrosamine: formation of mutagenic compounds by interaction with mouse liver microsomes
1971
Consensus statement * on the treatment of allergic rhinitis
2000
Local immunotherapy
1998
Prevalence of basidiomycete allergy in the USA and Europe and its relationship to allergic respiratory symptoms
1994
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
1998 Standout
Diagnosis and immunotherapy of mould allergy
1988
Immunotherapy with Hymenoptera venoms
1987
Reproducibility of Histamine Skin Prick Test
1985
Differential Response of a Double Mutant–adenineless, Inositolless-in Neurospora Crassa to Combined Treatment by Ultra-violet Radiation and Chemicals
1959
Diagnosis and immunotherapy of mould allergy
1988
Clustered Immunotherapy with Yellow Jacket Venom
1985
Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double‐blind, placebo‐controlled study
2014
Diagnosis and immunotherapy of mould allergy. VIII. Qualitative and quantitative estimation of IgE in Cladosporium immunotherapy.
1988
A sensitive and reproducible method for the determination of subnanogram quantities of immunoglobulin E (IgE)
1986
Isolation of 3′-deoxyadenosine (cordycepin) from the liquid medium of Cordyceps militaris (L. ex Fr.) Link
1965
The Ige and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regiments of venom immunotherapy
1985